FDA Adverse Event Malfunction Summary report: N

UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEM

MDR report key: 1083894 · Received July 28, 2008

Report

Report Number
2122870-2008-00231
Event Type
Malfunction
Date Received
July 28, 2008
Date of Event
July 4, 2008
Report Date
July 28, 2008
Manufacturer
BECKMAN COULTER, INC.
Product Code
MMI
PMA / PMN Number
K060256
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

PER CUSTOMER, QC WAS WITHIN EXPECTED RANGE THE DAY OF EVENT. MAINTENANCE AND SYSTEM CHECK HAD BEEN PERFORMED EARLIER THAT SHIFT WITH ALL PARAMETERS WITHIN SPECIFICATIONS. PER CUSTOMER, THEY TEND TO HAVE A PROBLEM WITH FIBRIN IN THE SPECIMENS COLLECTED IN THE ER AND PLANS TO EDUCATE THE ER STAFF ON PROPER SAMPLE HANDLING TECHNIQUES. A FIELD SERVICE ENGINEER (FSE) WAS NOT SENT FOR THIS EVENT. NO ADDITIONAL INFO REGARDING THIS EVENT IS AVAILABLE TO DATE. A CLEAR ROOT CAUSE FOR THIS EVENT HAS NOT BEEN DETERMINED. A MALFUNCTION WILL BE ASSUMED FOR THE PURPOSE OF THIS REPORT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI), REGARDING ERRONEOUSLY ELEVATED TROPONIN (ACCU TNI) RESULTS THAT WERE GENERATED BY THE UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEM FOR A SINGLE PT SAMPLE. AN INITIAL ACCU TNI RESULT OF 6.85NG/ML WAS REPORTED OUT OF THE LAB AND QUESTIONED BY THE PHYSICIAN. THE ORIGINAL SAMPLE WAS RE-TESTED AND REPEATED ACCU TNI RESULTS WERE 0.90NG/ML AND 0.28NG/ML. THE SAMPLE WAS TESTED ON A DIFFERENT INSTRUMENT IN THE CUSTOMER'S LAB AND TWO RESULTS OF 0.46 NG/ML WERE OBTAINED. CORRECTED REPORT WAS SENT. THERE HAVE BEEN NO REPORTS OF PT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL DXC 600I SYNCHRON ACCESS CLINICAL SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER MMI BECKMAN COULTER, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 NA